.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Primary cardiac sarcomas are exceptionally rare yet highly aggressive malignancies. Consequently, their preoperative diagnosis remains a significant challenge for clinical teams. Specifically, a left ventricular intimal sarcoma can radiologically mimic benign masses such as an organized thrombus. Therefore, clinicians must maintain a high index of suspicion when evaluating ambiguous cardiac lesions.
In a recent clinical case, a 45-year-old man presented with exertional dyspnea. Initial transthoracic echocardiography revealed a large, calcified mass in the left ventricle. Because this mass caused an outflow tract obstruction, clinicians initially suspected an organized thrombus. Furthermore, traditional imaging features like calcification and avascularity often suggest a benign nature. However, these features can camouflage a high-grade sarcoma. After the surgical resection, histopathology indicated a malignant mesenchymal tumor. Subsequently, MDM2 amplification confirmed the diagnosis of an intimal sarcoma.
Early identification is vital for patient survival. This case emphasizes the need to recognize specific red flag features during the diagnostic workflow. For instance, clinicians should consider genetic testing for any ambiguous left-sided mass. Integrating MDM2 testing into the pathology protocol helps distinguish intimal sarcoma from other subtypes. Moreover, definitive diagnosis guides lifesaving radical resection. Without this precise identification, patients may face catastrophic management delays. In contrast, appropriate radical surgery significantly improves the prognosis for these aggressive tumors.
Management of these tumors requires a multidisciplinary approach. Surgeons and oncologists must collaborate to ensure negative surgical margins. In addition, recognizing that classic imaging triads can be misleading is crucial. Aggressive management is often necessary to avoid the hazards of conservative treatment. Therefore, clinicians must remain vigilant to provide the best possible outcomes for patients with rare cardiac malignancies.
This tumor often mimics benign conditions like a thrombus or myxoma on imaging. It can present with calcification and lack of vascularity, which are typically associated with non-cancerous masses.
MDM2 genetic amplification is a hallmark of intimal sarcoma. Consequently, testing for this marker allows pathologists to confirm the diagnosis and distinguish it from other mesenchymal tumors.
The primary treatment is radical surgical resection. Early and aggressive intervention is necessary to prevent metastasis and manage outflow tract obstructions effectively.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ouyang Q et al. Left Ventricular Intimal Sarcoma Masquerading as a Benign Mass. JACC Case Rep. 2026 Mar 10. doi: undefined. PMID: 41805277.
Neuville A et al. Intimal sarcoma: clinicopathologic and molecular analysis of 100 cases and review of the literature. Am J Surg Pathol. 2014;38(4):461-469.
Ballout JA et al. Primary Cardiac Intimal Sarcoma: Multi-Layered Strategy and Core Role of MDM2 Amplification. Diagnostics (Basel). 2023;13(12):2066.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A case report on left ventricular intimal sarcoma mimicking a benign thrombus and the critical importance of MDM2 testing for definitive diagnosis....
7 months ago
Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today
Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
